Global Viral Inactivation Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Viral Inactivation Revenue
• 1.4 Market by Type
  • 1.4.1 Global Viral Inactivation Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Kits and Reagents
  • 1.4.3 Services
  • 1.4.4 Viral Inactivation Systems and Accessories
• 1.5 Market by Application
  • 1.5.1 Global Viral Inactivation Market Share by Application: 2020 VS 2026
  • 1.5.2 Blood and Blood Products
  • 1.5.3 Cellular and Gene Therapy Products
  • 1.5.4 Stem Cell Products
  • 1.5.5 Tissue and Tissue Products
  • 1.5.6 Vaccines and Therapeutics
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Viral Inactivation Market Perspective (2015-2026)
• 2.2 Global Viral Inactivation Growth Trends by Regions
  • 2.2.1 Viral Inactivation Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Viral Inactivation Historic Market Share by Regions (2015-2020)
  • 2.2.3 Viral Inactivation Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Viral Inactivation Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Viral Inactivation Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Viral Inactivation Players by Market Size
  • 3.1.1 Global Top Viral Inactivation Players by Revenue (2015-2020)
  • 3.1.2 Global Viral Inactivation Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Viral Inactivation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Viral Inactivation Market Concentration Ratio
  • 3.2.1 Global Viral Inactivation Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Viral Inactivation Revenue in 2019
• 3.3 Viral Inactivation Key Players Head office and Area Served
• 3.4 Key Players Viral Inactivation Product Solution and Service
• 3.5 Date of Enter into Viral Inactivation Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Viral Inactivation Historic Market Size by Type (2015-2020)
• 4.2 Global Viral Inactivation Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Viral Inactivation Market Size by Application (2015-2020)
• 5.2 Global Viral Inactivation Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Viral Inactivation Market Size (2015-2020)
• 6.2 Viral Inactivation Key Players in North America (2019-2020)
• 6.3 North America Viral Inactivation Market Size by Type (2015-2020)
• 6.4 North America Viral Inactivation Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Viral Inactivation Market Size (2015-2020)
• 7.2 Viral Inactivation Key Players in Europe (2019-2020)
• 7.3 Europe Viral Inactivation Market Size by Type (2015-2020)
• 7.4 Europe Viral Inactivation Market Size by Application (2015-2020)

8 China

• 8.1 China Viral Inactivation Market Size (2015-2020)
• 8.2 Viral Inactivation Key Players in China (2019-2020)
• 8.3 China Viral Inactivation Market Size by Type (2015-2020)
• 8.4 China Viral Inactivation Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Viral Inactivation Market Size (2015-2020)
• 9.2 Viral Inactivation Key Players in Japan (2019-2020)
• 9.3 Japan Viral Inactivation Market Size by Type (2015-2020)
• 9.4 Japan Viral Inactivation Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Viral Inactivation Market Size (2015-2020)
• 10.2 Viral Inactivation Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Viral Inactivation Market Size by Type (2015-2020)
• 10.4 Southeast Asia Viral Inactivation Market Size by Application (2015-2020)

11 India

• 11.1 India Viral Inactivation Market Size (2015-2020)
• 11.2 Viral Inactivation Key Players in India (2019-2020)
• 11.3 India Viral Inactivation Market Size by Type (2015-2020)
• 11.4 India Viral Inactivation Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Viral Inactivation Market Size (2015-2020)
• 12.2 Viral Inactivation Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Viral Inactivation Market Size by Type (2015-2020)
• 12.4 Central & South America Viral Inactivation Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Danaher
  • 13.1.1 Danaher Company Details
  • 13.1.2 Danaher Business Overview
  • 13.1.3 Danaher Viral Inactivation Introduction
  • 13.1.4 Danaher Revenue in Viral Inactivation Business (2015-2020))
  • 13.1.5 Danaher Recent Development
• 13.2 Merck
  • 13.2.1 Merck Company Details
  • 13.2.2 Merck Business Overview
  • 13.2.3 Merck Viral Inactivation Introduction
  • 13.2.4 Merck Revenue in Viral Inactivation Business (2015-2020)
  • 13.2.5 Merck Recent Development
• 13.3 Parker Hannifin
  • 13.3.1 Parker Hannifin Company Details
  • 13.3.2 Parker Hannifin Business Overview
  • 13.3.3 Parker Hannifin Viral Inactivation Introduction
  • 13.3.4 Parker Hannifin Revenue in Viral Inactivation Business (2015-2020)
  • 13.3.5 Parker Hannifin Recent Development
• 13.4 Sartorius
  • 13.4.1 Sartorius Company Details
  • 13.4.2 Sartorius Business Overview
  • 13.4.3 Sartorius Viral Inactivation Introduction
  • 13.4.4 Sartorius Revenue in Viral Inactivation Business (2015-2020)
  • 13.4.5 Sartorius Recent Development
• 13.5 SGS
  • 13.5.1 SGS Company Details
  • 13.5.2 SGS Business Overview
  • 13.5.3 SGS Viral Inactivation Introduction
  • 13.5.4 SGS Revenue in Viral Inactivation Business (2015-2020)
  • 13.5.5 SGS Recent Development
• 13.6 Charles River Laboratories International
  • 13.6.1 Charles River Laboratories International Company Details
  • 13.6.2 Charles River Laboratories International Business Overview
  • 13.6.3 Charles River Laboratories International Viral Inactivation Introduction
  • 13.6.4 Charles River Laboratories International Revenue in Viral Inactivation Business (2015-2020)
  • 13.6.5 Charles River Laboratories International Recent Development
• 13.7 Clean Cells
  • 13.7.1 Clean Cells Company Details
  • 13.7.2 Clean Cells Business Overview
  • 13.7.3 Clean Cells Viral Inactivation Introduction
  • 13.7.4 Clean Cells Revenue in Viral Inactivation Business (2015-2020)
  • 13.7.5 Clean Cells Recent Development
• 13.8 Rad Source Technologies
  • 13.8.1 Rad Source Technologies Company Details
  • 13.8.2 Rad Source Technologies Business Overview
  • 13.8.3 Rad Source Technologies Viral Inactivation Introduction
  • 13.8.4 Rad Source Technologies Revenue in Viral Inactivation Business (2015-2020)
  • 13.8.5 Rad Source Technologies Recent Development
• 13.9 Texcell
  • 13.9.1 Texcell Company Details
  • 13.9.2 Texcell Business Overview
  • 13.9.3 Texcell Viral Inactivation Introduction
  • 13.9.4 Texcell Revenue in Viral Inactivation Business (2015-2020)
  • 13.9.5 Texcell Recent Development
• 13.10 Viral Inactivated Plasma Systems
  • 13.10.1 Viral Inactivated Plasma Systems Company Details
  • 13.10.2 Viral Inactivated Plasma Systems Business Overview
  • 13.10.3 Viral Inactivated Plasma Systems Viral Inactivation Introduction
  • 13.10.4 Viral Inactivated Plasma Systems Revenue in Viral Inactivation Business (2015-2020)
  • 13.10.5 Viral Inactivated Plasma Systems Recent Development
• 13.11 Wuxi Pharmatech (Cayman)
  • 10.11.1 Wuxi Pharmatech (Cayman) Company Details
  • 10.11.2 Wuxi Pharmatech (Cayman) Business Overview
  • 10.11.3 Wuxi Pharmatech (Cayman) Viral Inactivation Introduction
  • 10.11.4 Wuxi Pharmatech (Cayman) Revenue in Viral Inactivation Business (2015-2020)
  • 10.11.5 Wuxi Pharmatech (Cayman) Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer